Dynavax Current Deferred Revenue from 2010 to 2024
| DVAX Stock | USD 12.96 0.03 0.23% |
Current Deferred Revenue | First Reported 2003-12-31 | Previous Quarter -4.4 M | Current Value 52.4 M | Quarterly Volatility 76.5 M |
Check Dynavax Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dynavax Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.7 M, Interest Expense of 4 M or Other Operating Expenses of 282.8 M, as well as many indicators such as Price To Sales Ratio of 7.36, Dividend Yield of 0.0 or PTB Ratio of 4.48. Dynavax financial statements analysis is a perfect complement when working with Dynavax Technologies Valuation or Volatility modules.
Dynavax | Current Deferred Revenue |
Latest Dynavax Technologies' Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Dynavax Technologies over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Dynavax Technologies' Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dynavax Technologies' overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Dynavax Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 36,404,549 | |
| Geometric Mean | 9,062,744 | |
| Coefficient Of Variation | 245.16 | |
| Mean Deviation | 47,357,641 | |
| Median | 5,865,000 | |
| Standard Deviation | 89,248,176 | |
| Sample Variance | 7965.2T | |
| Range | 352.9M | |
| R-Value | 0.40 | |
| Mean Square Error | 7202.8T | |
| R-Squared | 0.16 | |
| Significance | 0.14 | |
| Slope | 7,990,486 | |
| Total Sum of Squares | 111513.3T |
Dynavax Current Deferred Revenue History
About Dynavax Technologies Financial Statements
Dynavax Technologies investors use historical fundamental indicators, such as Dynavax Technologies' Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dynavax Technologies. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 60.3 M | 31 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Dynavax Stock Analysis
When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.